The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) Community Study (RaDIANT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02092727|
Recruitment Status : Completed
First Posted : March 20, 2014
Last Update Posted : February 21, 2018
|Condition or disease||Intervention/treatment||Phase|
|Kidney Disease||Behavioral: Behavioral Interventions for Dialysis Facilities||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||134 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) Community Study|
|Study Start Date :||February 2014|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||January 2018|
No Intervention: Control
Standard of care arm will receive no specific interventions, but will have access to standard educational materials and quality improvement through End Stage Renal Disease Network 6.
Experimental: Behavioral Intervention
A variety of dialysis facility-level, behavioral interventions will be examined.
Behavioral: Behavioral Interventions for Dialysis Facilities
- Referral for Kidney Transplantation [ Time Frame: One Year ]Following a multicomponent intervention at the dialysis facility level, change in referral for kidney transplantation from baseline to follow-up (at one year) will be calculated.
- Reduction in Racial Disparity [ Time Frame: One Year ]Following a multicomponent intervention at the dialysis facility level, reduction in racial disparity (African American vs. Caucasian) of referral for transplantation (from baseline to one year follow up) will be calculated.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02092727
|United States, Georgia|
|Dialysis Facilities throughout the State of Georgia, ESRD Network 6|
|Atlanta, Georgia, United States, 30322|
|Principal Investigator:||Rachel E Patzer, PhD, MPH||Emory University|